Featured Research

from universities, journals, and other organizations

Chemical Genomic Screening Identifies Novel Therapeutic Strategies For Cancer

Date:
October 11, 2006
Source:
Cell Press
Summary:
A sophisticated new chemical genetic screening strategy that serves as a tool for identifying anticancer compounds may significantly enhance the drug discovery process. Two research papers that describe using this exciting gene expression-based chemical genomic strategy to identify therapeutics for cancer phenotypes previously associated with a poor prognosis and to gain new insight into cancer biology are publishing online on September 28th, and in the October 2006 print issue of the journal Cancer Cell, published by Cell Press.

A sophisticated new chemical genetic screening strategy that serves as a tool for identifying anticancer compounds may significantly enhance the drug discovery process. Two research papers that describe using this exciting gene expression-based chemical genomic strategy to identify therapeutics for cancer phenotypes previously associated with a poor prognosis and to gain new insight into cancer biology are publishing online on September 28th, and in the October 2006 print issue of the journal Cancer Cell, published by Cell Press.

Related Articles


Dr. Todd R. Golub and colleagues, from the Dana-Farber Cancer Institute, the Broad Institute of MIT, and Harvard Medical School, identified compounds that inhibit androgen receptor (AR)-mediated signaling. AR signaling plays a critical role in the progression of prostate cancer, even in patients whose androgen level is dramatically reduced through androgen ablation therapy. Currently, there are very few clinically effective AR signaling inhibitors. By applying a gene expression signature-based screening approach, Dr. Golub's group was able to identify two chemical compounds derived from plants with a medicinal history, celastrol and gedunin, as potent inhibitors of AR signaling.

The researchers then used a computational tool they named the Connectivity Map to compare gene expression signatures evoked by these compounds with the gene expression signatures of drugs that had established biological activities. This comparison revealed that celastrol and gedunin inhibit heat-shock protein 90 (HSP90). HSP90 has been under intensive investigation as a target for cancer therapy in recent years. However, the structures of celastrol and gedunin and how they interact with HSP90 differ from currently known HSP90 inhibitors. Therefore, these structurally and mechanistically novel modulators of HSP90 open unique scientific and therapeutic avenues.

In a separate study, researchers, led by Scott A. Armstrong of Children's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, attempted to overcome glucocorticoid (GC) resistance in childhood acute lymphoblastic leukemia (ALL). Resistance to treatment with GC is a strong predictor of poor prognosis in ALL, but the precise explanation for sensitivity versus resistance to GC in ALL as well as how to overcome GC resistance is not clear. These researchers applied gene expression analysis to identify genetic signatures associated with GC-sensitive and GC-resistant ALL samples. They then used these genetic signatures to query a database derived from many biologically active compounds by using the Connectivity Map approach. This comparison revealed that the compound rapamycin is an agent capable of potentially reversing the GC resistance signature. The researchers further demonstrated that rapamycin modulates a signaling molecule linked to cell death and suggested that combination therapy with rapamycin and GC may be useful for treatment of ALL.

Results from these two studies demonstrate that the gene expression-based chemical genomic approach represents a strategy for identification of promising new therapies for cancer. "Chemical genomics has the potential to identify modulators of complex cancer phenotypes, predict their activities, and subsequently establish their mechanisms of actions with little prior knowledge about underlying mechanisms," offers Dr. Golub.

The researchers include Guo Wei of Dana Farber Cancer Institute and Harvard Medical School and The Broad Institute of Harvard University and Massachusetts Institute of Technology; David Twomey of Children's Hospital and Harvard Medical School and The Broad Institute of Harvard University and Massachusetts Institute of Technology; Justin Lamb of The Broad Institute of Harvard University and Massachusetts Institute of Technology; Krysta Schlis, Stephen E. Sallan, and Scott A. Armstrong of Children's Hospital, Dana Farber Cancer Institute, and Harvard Medical School; Jyoti Agarwal of Children's Hospital and Harvard Medical School; Ronald W. Stam, Monique L. den Boer, and Rob Pieters of Sophia Children's Hospital, Erasmus University Medical Center; Joseph T. Opferman of St. Jude Children's Research Hospital; and Todd R. Golub of Dana Farber Cancer Institute and Harvard Medical School, The Broad Institute of Harvard University and Massachusetts Institute of Technology, and Howard Hughes Medical Institute.

This work was supported by The Leukemia Lymphoma Society (S.A.A), Damon Runyon Cancer Research foundation (S.A.A)(G.W), and the National Cancer Institute (NCI grants K08 CA92551 and PO1 CA068484).


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Chemical Genomic Screening Identifies Novel Therapeutic Strategies For Cancer." ScienceDaily. ScienceDaily, 11 October 2006. <www.sciencedaily.com/releases/2006/09/060929094251.htm>.
Cell Press. (2006, October 11). Chemical Genomic Screening Identifies Novel Therapeutic Strategies For Cancer. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2006/09/060929094251.htm
Cell Press. "Chemical Genomic Screening Identifies Novel Therapeutic Strategies For Cancer." ScienceDaily. www.sciencedaily.com/releases/2006/09/060929094251.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins